E
Evome Medical Technologies Inc.
EVMT.V
TSX
E
Sell
1/6/2025Downgrade
Evome Medical Technologies Inc. (EVMT.V) was downgraded to E+ from D- on 1/6/2025 due to a noticeable decline in the growth index, volatility index and solvency index. Operating cash flow declined 42.62% from $2.28M to $1.31M, debt to equity increased from -6.13 to -3.82, and the quick ratio declined from 0.19 to 0.18.
Evome Medical Technologies Inc. (EVMT.V) was downgraded to E+ from D- on 1/6/2025 due to a noticeable decline in the growth index, volatility index and solvency index. Operating cash flow declined 42.62% from $2.28M to $1.31M, debt to equity increased from -6.13 to -3.82, and the quick ratio declined from 0.19 to 0.18.
D
Sell
11/15/2024Upgraded
Evome Medical Technologies Inc. (EVMT.V) was upgraded to D- from E+ on 11/15/2024 due to an increase in the volatility index and valuation index.
Evome Medical Technologies Inc. (EVMT.V) was upgraded to D- from E+ on 11/15/2024 due to an increase in the volatility index and valuation index.
E
Sell
2/21/2024Downgrade
Evome Medical Technologies Inc. (EVMT.V) was downgraded to E+ from D- on 2/21/2024 due to a decline in the volatility index, total return index and solvency index.
Evome Medical Technologies Inc. (EVMT.V) was downgraded to E+ from D- on 2/21/2024 due to a decline in the volatility index, total return index and solvency index.
D
Sell
6/23/2023Upgraded
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D- from E+ on 6/23/2023 due to an increase in the volatility index.
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D- from E+ on 6/23/2023 due to an increase in the volatility index.
E
Sell
6/8/2023Downgrade
Salona Global Medical Device Corporation (SGMD.V) was downgraded to E+ from D- on 6/8/2023 due to a decline in the volatility index and total return index.
Salona Global Medical Device Corporation (SGMD.V) was downgraded to E+ from D- on 6/8/2023 due to a decline in the volatility index and total return index.
D
Sell
5/24/2023Upgraded
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D- from E+ on 5/24/2023 due to an increase in the volatility index and growth index. Earnings per share increased from -$0.0223 to -$0.0197, and total revenue increased 0.48% from $7.66M to $7.69M.
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D- from E+ on 5/24/2023 due to an increase in the volatility index and growth index. Earnings per share increased from -$0.0223 to -$0.0197, and total revenue increased 0.48% from $7.66M to $7.69M.
E
Sell
5/23/2023Downgrade
Salona Global Medical Device Corporation (SGMD.V) was downgraded to E+ from D- on 5/23/2023 due to a decline in the volatility index and total return index.
Salona Global Medical Device Corporation (SGMD.V) was downgraded to E+ from D- on 5/23/2023 due to a decline in the volatility index and total return index.
D
Sell
5/8/2023Upgraded
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D- from E+ on 5/8/2023 due to an increase in the volatility index.
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D- from E+ on 5/8/2023 due to an increase in the volatility index.
E
Sell
4/21/2023Downgrade
Salona Global Medical Device Corporation (SGMD.V) was downgraded to E+ from D- on 4/21/2023 due to a noticeable decline in the volatility index and total return index.
Salona Global Medical Device Corporation (SGMD.V) was downgraded to E+ from D- on 4/21/2023 due to a noticeable decline in the volatility index and total return index.
D
Sell
3/14/2023Downgrade
Salona Global Medical Device Corporation (SGMD.V) was downgraded to D- from D on 3/14/2023 due to a decline in the volatility index and total return index.
Salona Global Medical Device Corporation (SGMD.V) was downgraded to D- from D on 3/14/2023 due to a decline in the volatility index and total return index.
D
Sell
2/23/2023Upgraded
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index.
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D from D- on 2/23/2023 due to an increase in the total return index.
D
Sell
2/8/2023Downgrade
Salona Global Medical Device Corporation (SGMD.V) was downgraded to D- from D on 2/8/2023 due to a decline in the volatility index and growth index. Total revenue declined 0.24% from $7.67M to $7.66M.
Salona Global Medical Device Corporation (SGMD.V) was downgraded to D- from D on 2/8/2023 due to a decline in the volatility index and growth index. Total revenue declined 0.24% from $7.67M to $7.66M.
D
Sell
10/18/2022Downgrade
Salona Global Medical Device Corporation (SGMD.V) was downgraded to D from D+ on 10/18/2022 due to a significant decline in the total return index, solvency index and growth index. Earnings per share declined from -$0.0472 to -$0.1397, debt to equity increased from 0.26 to 0.46, and the quick ratio declined from 1.01 to 0.59.
Salona Global Medical Device Corporation (SGMD.V) was downgraded to D from D+ on 10/18/2022 due to a significant decline in the total return index, solvency index and growth index. Earnings per share declined from -$0.0472 to -$0.1397, debt to equity increased from 0.26 to 0.46, and the quick ratio declined from 1.01 to 0.59.
D
Sell
7/15/2022Upgraded
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D+ from D on 7/15/2022 due to an increase in the valuation index and solvency index. The quick ratio increased from 0.59 to 1.01, and debt to equity declined from 0.5 to 0.26.
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D+ from D on 7/15/2022 due to an increase in the valuation index and solvency index. The quick ratio increased from 0.59 to 1.01, and debt to equity declined from 0.5 to 0.26.
D
Sell
7/11/2022Downgrade
Salona Global Medical Device Corporation (SGMD.V) was downgraded to D from D+ on 7/11/2022 due to a decline in the total return index and valuation index.
Salona Global Medical Device Corporation (SGMD.V) was downgraded to D from D+ on 7/11/2022 due to a decline in the total return index and valuation index.
D
Sell
6/2/2022Upgraded
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D+ from D on 6/2/2022 due to a significant increase in the total return index, growth index and valuation index. Earnings per share increased from -$0.0267 to -$0.018.
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D+ from D on 6/2/2022 due to a significant increase in the total return index, growth index and valuation index. Earnings per share increased from -$0.0267 to -$0.018.
D
Sell
5/5/2022Upgraded
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D from D- on 5/5/2022 due to an increase in the total return index.
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D from D- on 5/5/2022 due to an increase in the total return index.
D
Sell
4/20/2022Downgrade
Salona Global Medical Device Corporation (SGMD.V) was downgraded to D- from D on 4/20/2022 due to a decline in the valuation index.
Salona Global Medical Device Corporation (SGMD.V) was downgraded to D- from D on 4/20/2022 due to a decline in the valuation index.
D
Sell
4/18/2022Downgrade
Salona Global Medical Device Corporation (SGMD.V) was downgraded to D from D+ on 4/18/2022 due to a noticeable decline in the solvency index, total return index and volatility index. The quick ratio declined from 0.73 to 0.39, and debt to equity increased from 0.54 to 0.62.
Salona Global Medical Device Corporation (SGMD.V) was downgraded to D from D+ on 4/18/2022 due to a noticeable decline in the solvency index, total return index and volatility index. The quick ratio declined from 0.73 to 0.39, and debt to equity increased from 0.54 to 0.62.
D
Sell
11/22/2021Upgraded
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D+ from D- on 11/22/2021 due to an increase in the valuation index.
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D+ from D- on 11/22/2021 due to an increase in the valuation index.
D
Sell
11/8/2021Downgrade
Salona Global Medical Device Corporation (SGMD.V) was downgraded to D- from D on 11/8/2021 due to a decline in the volatility index and growth index.
Salona Global Medical Device Corporation (SGMD.V) was downgraded to D- from D on 11/8/2021 due to a decline in the volatility index and growth index.
D
Sell
10/22/2021Downgrade
Salona Global Medical Device Corporation (SGMD.V) was downgraded to D from D+ on 10/22/2021 due to a large decline in the total return index, growth index and volatility index. Earnings per share declined from -$0.0161 to -$0.0195.
Salona Global Medical Device Corporation (SGMD.V) was downgraded to D from D+ on 10/22/2021 due to a large decline in the total return index, growth index and volatility index. Earnings per share declined from -$0.0161 to -$0.0195.
D
Sell
7/23/2021Upgraded
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D+ from D on 7/23/2021 due to a significant increase in the total return index, growth index and volatility index. Total revenue increased 723.12% from $57.1 to $470, and earnings per share increased from -$0.047 to -$0.0146.
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D+ from D on 7/23/2021 due to a significant increase in the total return index, growth index and volatility index. Total revenue increased 723.12% from $57.1 to $470, and earnings per share increased from -$0.047 to -$0.0146.
D
Sell
5/28/2021Upgraded
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D from D- on 5/28/2021 due to an increase in the valuation index.
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D from D- on 5/28/2021 due to an increase in the valuation index.
D
Sell
5/6/2021Upgraded
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D- from E+ on 5/6/2021 due to a noticeable increase in the total return index and volatility index.
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D- from E+ on 5/6/2021 due to a noticeable increase in the total return index and volatility index.
E
Sell
4/21/2021Downgrade
Salona Global Medical Device Corporation (SGMD.V) was downgraded to E+ from D- on 4/21/2021 due to a noticeable decline in the solvency index and volatility index.
Salona Global Medical Device Corporation (SGMD.V) was downgraded to E+ from D- on 4/21/2021 due to a noticeable decline in the solvency index and volatility index.
D
Sell
4/6/2021Upgraded
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D- from E+ on 4/6/2021 due to an increase in the total return index and volatility index.
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D- from E+ on 4/6/2021 due to an increase in the total return index and volatility index.
E
Sell
3/22/2021Downgrade
Salona Global Medical Device Corporation (SGMD.V) was downgraded to E+ from D- on 3/22/2021 due to a decline in the volatility index.
Salona Global Medical Device Corporation (SGMD.V) was downgraded to E+ from D- on 3/22/2021 due to a decline in the volatility index.
D
Sell
3/4/2021Upgraded
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D- from E+ on 3/4/2021 due to an increase in the volatility index and total return index.
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D- from E+ on 3/4/2021 due to an increase in the volatility index and total return index.
E
Sell
2/12/2021Downgrade
Salona Global Medical Device Corporation (SGMD.V) was downgraded to E+ from D- on 2/12/2021 due to a decline in the volatility index.
Salona Global Medical Device Corporation (SGMD.V) was downgraded to E+ from D- on 2/12/2021 due to a decline in the volatility index.
D
Sell
1/27/2021Upgraded
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D- from E+ on 1/27/2021 due to an increase in the volatility index, valuation index and total return index.
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D- from E+ on 1/27/2021 due to an increase in the volatility index, valuation index and total return index.
E
Sell
1/21/2021Downgrade
Salona Global Medical Device Corporation (SGMD.V) was downgraded to E+ from D- on 1/21/2021 due to a decline in the volatility index and total return index.
Salona Global Medical Device Corporation (SGMD.V) was downgraded to E+ from D- on 1/21/2021 due to a decline in the volatility index and total return index.
D
Sell
1/5/2021Upgraded
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D- from E+ on 1/5/2021 due to an increase in the volatility index.
Salona Global Medical Device Corporation (SGMD.V) was upgraded to D- from E+ on 1/5/2021 due to an increase in the volatility index.
E
Sell
12/14/2020Downgrade
Brattle Street Investment Corp. (BRTL.V) was downgraded to E+ from D- on 12/14/2020 due to a decline in the total return index and volatility index.
Brattle Street Investment Corp. (BRTL.V) was downgraded to E+ from D- on 12/14/2020 due to a decline in the total return index and volatility index.
D
Sell
11/16/2020Upgraded
Brattle Street Investment Corp. (BRTL.V) was upgraded to D- from E+ on 11/16/2020 due to an increase in the growth index, volatility index and total return index. Total revenue increased 189.02% from -$65.6 to $58.4, and operating cash flow increased 20.19% from -$156.5 to -$124.9.
Brattle Street Investment Corp. (BRTL.V) was upgraded to D- from E+ on 11/16/2020 due to an increase in the growth index, volatility index and total return index. Total revenue increased 189.02% from -$65.6 to $58.4, and operating cash flow increased 20.19% from -$156.5 to -$124.9.
E
Sell
6/26/2020Downgrade
Brattle Street Investment Corp. (BRTL.V) was downgraded to E+ from D on 6/26/2020 due to a decline in the growth index, solvency index and volatility index.
Brattle Street Investment Corp. (BRTL.V) was downgraded to E+ from D on 6/26/2020 due to a decline in the growth index, solvency index and volatility index.
D
Sell
5/20/2020Upgraded
Brattle Street Investment Corp. (BRTL.V) was upgraded to D from D- on 5/20/2020 due to a noticeable increase in the growth index and total return index.
Brattle Street Investment Corp. (BRTL.V) was upgraded to D from D- on 5/20/2020 due to a noticeable increase in the growth index and total return index.
D
Sell
3/27/2020Downgrade
Brattle Street Investment Corp. (BRTL.V) was downgraded to D- from D on 3/27/2020 due to a decline in the growth index and efficiency index. Operating cash flow declined 158.58% from -$47.8 to -$123.6, total revenue declined 72.16% from $529.5 to $147.4, and total capital declined 0.28% from $8.96M to $8.93M.
Brattle Street Investment Corp. (BRTL.V) was downgraded to D- from D on 3/27/2020 due to a decline in the growth index and efficiency index. Operating cash flow declined 158.58% from -$47.8 to -$123.6, total revenue declined 72.16% from $529.5 to $147.4, and total capital declined 0.28% from $8.96M to $8.93M.
D
Sell
7/12/2019Upgraded
Inspira Financial Inc. (LND.V) was upgraded to D from E+ on 7/12/2019 due to a significant increase in the solvency index, growth index and efficiency index.
Inspira Financial Inc. (LND.V) was upgraded to D from E+ on 7/12/2019 due to a significant increase in the solvency index, growth index and efficiency index.
E
Sell
7/1/2019Downgrade
Inspira Financial Inc. (LND.V) was downgraded to E+ from D- on 7/1/2019 due to a significant decline in the solvency index, efficiency index and total return index.
Inspira Financial Inc. (LND.V) was downgraded to E+ from D- on 7/1/2019 due to a significant decline in the solvency index, efficiency index and total return index.
D
Sell
3/29/2019Upgraded
Inspira Financial Inc. (LND.V) was upgraded to D- from E+ on 3/29/2019 due to an increase in the total return index, volatility index and solvency index.
Inspira Financial Inc. (LND.V) was upgraded to D- from E+ on 3/29/2019 due to an increase in the total return index, volatility index and solvency index.
E
Sell
8/6/2018Downgrade
Inspira Financial Inc. (LND.V) was downgraded to E+ from D- on 8/6/2018 due to a decline in the dividend index.
Inspira Financial Inc. (LND.V) was downgraded to E+ from D- on 8/6/2018 due to a decline in the dividend index.
D
Sell
7/20/2018Upgraded
Inspira Financial Inc. (LND.V) was upgraded to D- from E+ on 7/20/2018 due to an increase in the dividend index.
Inspira Financial Inc. (LND.V) was upgraded to D- from E+ on 7/20/2018 due to an increase in the dividend index.
E
Sell
7/5/2018Downgrade
Inspira Financial Inc. (LND.V) was downgraded to E+ from D- on 7/5/2018 due to a large decline in the efficiency index, growth index and solvency index. Net income declined 5,693.46% from -$100.9 to -$5.85M, earnings per share declined from -$0.0024 to -$0.1278, and total revenue declined 713.01% from $743.1 to -$4.56M.
Inspira Financial Inc. (LND.V) was downgraded to E+ from D- on 7/5/2018 due to a large decline in the efficiency index, growth index and solvency index. Net income declined 5,693.46% from -$100.9 to -$5.85M, earnings per share declined from -$0.0024 to -$0.1278, and total revenue declined 713.01% from $743.1 to -$4.56M.
D
Sell
11/2/2017Downgrade
Inspira Financial Inc. (LND.V) was downgraded to D- from D on 11/2/2017 due to a decline in the dividend index, growth index and total return index. Operating cash flow declined 99.32% from $2.73M to $18.6, and total revenue declined 12.3% from $826 to $724.4.
Inspira Financial Inc. (LND.V) was downgraded to D- from D on 11/2/2017 due to a decline in the dividend index, growth index and total return index. Operating cash flow declined 99.32% from $2.73M to $18.6, and total revenue declined 12.3% from $826 to $724.4.
D
Sell
10/17/2017Upgraded
Inspira Financial Inc. (LND.V) was upgraded to D from D- on 10/17/2017 due to a noticeable increase in the growth index, dividend index and valuation index. Earnings per share increased from -$0.1277 to -$0.0092, and total revenue increased 71.16% from $482.6 to $826.
Inspira Financial Inc. (LND.V) was upgraded to D from D- on 10/17/2017 due to a noticeable increase in the growth index, dividend index and valuation index. Earnings per share increased from -$0.1277 to -$0.0092, and total revenue increased 71.16% from $482.6 to $826.
D
Sell
12/3/2014Upgraded
Chrysalis Capital IX Corporation (NYNP.V) was upgraded to D- from E+ on 12/3/2014 due to an increase in the valuation index and volatility index.
Chrysalis Capital IX Corporation (NYNP.V) was upgraded to D- from E+ on 12/3/2014 due to an increase in the valuation index and volatility index.
E
Sell
9/5/2014Upgraded
Chrysalis Capital IX Corporation (NYNP.V) was upgraded to E+ from E on 9/5/2014 due to a large increase in the growth index and valuation index.
Chrysalis Capital IX Corporation (NYNP.V) was upgraded to E+ from E on 9/5/2014 due to a large increase in the growth index and valuation index.
E
Sell
8/12/2014None
Evome Medical Technologies Inc. (EVMT.V) was downgraded to E from U on 08/12/2014.
Evome Medical Technologies Inc. (EVMT.V) was downgraded to E from U on 08/12/2014.
